 |
David M Brown; David S Boyer; Diana V Do; Charles C Wykoff; Taiji Sakamoto; Peter Win; Sunir Joshi; Hani Salehi-Had; Seres András; Alyson J Berliner; Sergio Leal; Robert Vitti; Karen W Chu; Kimberly Reed; Rohini Rao; Yenchieh Cheng; Wei Sun; Delia Voronca; Rafia Bhore; Ursula Schmidt-Ott; Thomas Schmelter; Andrea Schulze; Xin Zhang; Boaz Hirshberg; George D Yancopoulos; Sobha Sivaprasad; Kollaborációs szervezet: PHOTON Investigators; Bátor György; Kerényi Ágnes; Kiss Katalin; Milibák Tibor; Papp András; Seres András; Tóth-Molnár Edit; Vajas Attila; Varsányi Balázs:
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON) : 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
LANCET, 403 (10432).
pp. 1153-1163.
ISSN 0140-6736
(2024)
Jackson Timothy L.; Slakter Jason; Buyse Marc; Wang Kun; Dugel Pravin U.; Wykoff Charles C.; Boyer David S.; Gerometta Michael; Baldwin Megan E.; Price Clare F.; Kollaborációs szervezet: Opthea Study Group Investigator; Facskó Andrea; Kerényi Ágnes; Papp András; Vogt Gábor; et al.:
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration.
OPHTHALMOLOGY, 130 (6).
pp. 588-597.
ISSN 0161-6420
(2023)
![[Fel]](/style/images/multi_up.png)
Vissza
